Plasma Estradiol and Endometrial Edema Profile in Acyclic Mares After Single Administration of 17-β Estradiol, Estradiol Benzoate and Estradiol Cypionate

单次注射17-β雌二醇、苯甲酸雌二醇和环戊丙酸雌二醇后,无周期母马血浆雌二醇和子宫内膜水肿的变化

阅读:1

Abstract

A longer endometrial exposure to estradiol before progesterone has been shown to be beneficial in cyclic and acyclic recipient mares. Therefore, the selection of an estradiol ester that promotes longer endometrial exposure to estradiol using a single administration would be advantageous when preparing acyclic mares as embryo recipients. This study investigated plasma estradiol profiles in acyclic mares after a single administration of 17-β estradiol (17-β), estradiol benzoate (EB) and estradiol cypionate (EC), and the correlation between plasma concentrations and endometrial edema. Fifteen non-cyclic mares were divided into groups 17-β (n = 5), EB (n = 5) or EC (n = 5), receiving a single dose of 10 mg of the respective hormone. Blood sample collections and transrectal ultrasonography were performed every 6 h from hour 0 to 12, every 12 h from 12 to 48 h, and every 24 h from 48 to 120 h after hormone administration. Five of the acyclic mares were used during the breeding season as a cyclic control. Greater median concentrations were detected using EB (38.6 pg/mL; p < 0.05). For 17-β, peak concentration was observed at 6 h (29.7 pg/mL) and decreased 24 h after administration (5.9 pg/mL; p < 0.05). In the EC group, there was a modest peak starting from 12 h (11.7 pg/mL; p < 0.05), remaining relatively constant until 120 h. A more rapid increase of edema to moderate and high scores was found when using 17β estradiol, although edema scores and persistence until Day 5 were similar among the oestrogens used. A correlation between estradiol concentration and endometrial edema was only seen when using EC, and this hormone also produced the most similar concentration values to those found in natural cycling mares. Therefore, it is likely that EC would be a suitable hormone for preparing acyclic mares as embryo recipients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。